Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients

被引：0
|
作者：
Zaazouee, Mohamed Sayed [1 ]
Elsnhory, Ahmed [2 ]
Ebrahim, Rokaya Y. [3 ]
Al-araj, Ghaida'a [4 ]
Saad, Ahmed [5 ]
Zaki, Ibram [6 ]
Ali, Mustafa Hussein [7 ]
Fawy, Omar Khaled Fahmy [8 ]
Ahmed, Hadi F. [9 ]
Elshennawy, Mohamed [1 ]
Eleyan, Mohammed [10 ]
Alahmad, Ziad [11 ]
Hamra, Reem I. Abo [12 ]
AbuEl-Enien, Hazem [13 ]
Elromely, Rasha Abdo [14 ]
Elshanbary, Alaa Ahmed [14 ]
机构：
[1] Al Azhar Univ, Fac Med, Assiut, Egypt
[2] Al Azhar Univ, Fac Med, Cairo, Egypt
[3] Alexandria Univ, Dept Biotechnol, Fac Sci, Alexandria, Egypt
[4] Al Balqa Appl Univ, Fac Med, Salt, Jordan
[5] Menoufia Univ, Fac Med, Menoufia, Egypt
[6] Beni Suef Univ, Fac Med, Bani Suwayf, Egypt
[7] Al Taff Univ Coll, Dept Anesthesia Tech & Intens care, Karbala, Iraq
[8] Helwan Univ, Fac Med, Helwan, Egypt
[9] Red Sea Univ, Fac Med & Hlth Sci, Port Sudan, Sudan
[10] Al Aqsa Univ, Dept Lab Med Sci, Gaza, Palestine
[11] Univ Aleppo, Fac Med, Aleppo, Syria
[12] Al Quds Univ, Fac Med, Gaza, Palestine
[13] Pharos Univ, Fac Pharm & Drug Mfg, Alexandria, Egypt
[14] Alexandria Univ, Fac Med, Alexandria, Egypt
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203515
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P10-12.003
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    McAllister, Peter
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Ning, Xiaoping
    Janka, Lindsay
    Barash, Steve
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [42] Early onset of efficacy with erenumab in patients with episodic and chronic migraine
    Schwedt, Todd
    Reuter, Uwe
    Tepper, Stewart
    Ashina, Messoud
    Kudrow, David
    Broessner, Gregor
    Boudreau, Guy P.
    McAllister, Peter
    Vu, Thuy
    Zhang, Feng
    Cheng, Sunfa
    Picard, Hernan
    Wen, Shihua
    Kahn, Joseph
    Klatt, Jan
    Mikol, Daniel
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [43] Pooled Analysis of Tolerability With Fremanezumab Treatment in Patients With Episodic or Chronic Migraine and Cardiovascular Medication Use at Baseline
    Coppola, G.
    Cohen, J. M.
    Ning, X.
    Kessler, Y.
    Yang, R.
    Barbanti, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 156 - 156
  • [44] Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Peter McAllister
    Joshua M. Cohen
    Verena Ramirez Campos
    Xiaoping Ning
    Lindsay Janka
    Steve Barash
    The Journal of Headache and Pain, 2022, 23
  • [45] Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
    Shibata, Mamoru
    Nihira, Atsuko
    Tanji, Yuka
    Ozeki, Akichika
    Imagawa, Hideyuki
    Komori, Mika
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 2007 - 2019
  • [46] Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
    Mamoru Shibata
    Atsuko Nihira
    Yuka Tanji
    Akichika Ozeki
    Hideyuki Imagawa
    Mika Komori
    Neurology and Therapy, 2023, 12 : 2007 - 2019
  • [47] Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
    Diener, H. -C.
    Dodick, D. W.
    Turkel, C. C.
    Demos, G.
    DeGryse, R. E.
    Earl, N. L.
    Brin, M. F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 851 - 859
  • [48] Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review
    Membrilla, Javier A.
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Caronna, Edoardo
    Pozo-Rosich, Patricia
    HEADACHE, 2022, 62 (10): : 1395 - 1405
  • [49] Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
    Schwedt, Todd J.
    Oakes, Tina M. Myers
    Martinez, James M.
    Vargas, Bert B.
    Pandey, Hitendra
    Pearlman, Eric M.
    Richardson, Diane R.
    Varnado, Oralee J.
    Meyer, Michael Cobas
    Goadsby, Peter J.
    NEUROLOGY AND THERAPY, 2024, 13 (01) : 85 - 105
  • [50] Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
    Zhao, Xiuyuan
    Xu, Xiaolin
    Li, Qingyun
    JOURNAL OF NEUROLOGY, 2021, 268 (07) : 2364 - 2376
12345